Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
暂无分享,去创建一个
F. Fernández-Cuenca | Á. Pascual | J. Rodríguez-Martínez | P. Díaz de Alba | A. Briales | Pedro Fernández-Echauri
[1] P. Nordmann,et al. Extended-Spectrum Cephalosporinase in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[2] P. Nordmann,et al. Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa , 2009, Antimicrobial Agents and Chemotherapy.
[3] G. Jacoby,et al. SOS Regulation of qnrB Expression , 2008, Antimicrobial Agents and Chemotherapy.
[4] M. Galleni,et al. Structure of the plasmid-mediated class C beta-lactamase ACT-1. , 2008, Acta Crystallographica. Section F : Structural Biology and Crystallization Communications.
[5] P. Nordmann,et al. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli. , 2008, FEMS microbiology letters.
[6] A. Oliver,et al. Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals , 2007, Antimicrobial Agents and Chemotherapy.
[7] H. Nordmann. Extended-Spectrum Cephalosporinases in Enterobacteriaceae , 2007 .
[8] F. Fernández-Cuenca,et al. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. , 2006, International journal of antimicrobial agents.
[9] G. Barnaud,et al. Selection during Cefepime Treatment of a New Cephalosporinase Variant with Extended-Spectrum Resistance to Cefepime in an Enterobacter aerogenes Clinical Isolate , 2004, Antimicrobial Agents and Chemotherapy.
[10] B. Hall,et al. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC beta-lactamase. , 2003, Genetics.
[11] S. Mobashery,et al. Mutational Replacement of Leu-293 in the Class C Enterobacter cloacae P99 β-Lactamase Confers Increased MIC of Cefepime , 2002, Antimicrobial Agents and Chemotherapy.
[12] G. Barnaud,et al. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. , 2001, FEMS microbiology letters.
[13] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[14] R. Venezia,et al. Nucleotide Sequence of the ChromosomalampC Gene of Enterobacter aerogenes , 2000, Antimicrobial Agents and Chemotherapy.
[15] T. Sawai,et al. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion. , 1999, Biochemistry.
[16] R. Hancock,et al. Antibacterial in vitro activity of fourth generation cephalosporins. , 1996, Journal of chemotherapy.
[17] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.